{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:54:55Z","timestamp":1761101695017,"version":"3.43.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1023\/b:glyc.0000046272.38480.ef","type":"journal-article","created":{"date-parts":[[2004,10,28]],"date-time":"2004-10-28T23:18:34Z","timestamp":1099005514000},"page":"295-304","source":"Crossref","is-referenced-by-count":39,"title":["Glycosphingolipidoses: Beyond the enzymatic defect"],"prefix":"10.1007","volume":"21","author":[{"given":"Annick","family":"Raas-Rothschild","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Pankova-Kholmyansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaacov","family":"Kacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony H.","family":"Futerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5277594_CR1","unstructured":"Hopwood JJ, Brooks DA, An introduction to the basic science and biology of the lysosome and storage diseases. In Organelle Disease, edited by Applegarth DA, Dimmick JE, Hall J (Chapman and Hall Medical, 1997), pp. 7-36."},{"key":"5277594_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nrm1423","volume":"5","author":"A Futerman","year":"2004","unstructured":"Futerman A, van Meer G, The cell biology of lysosomal stor-age disorders, Nature Reviews Molecular Cell Biology\n                  5, 554-65 (2004).","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"5277594_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1023\/B:GLYC.0000016741.88476.8b","volume":"20","author":"M Bektas","year":"2004","unstructured":"Bektas M, Spiegel S, Glycosphingolipids and cell death, Glycoconj J\n                  20, 39-47 (2004).","journal-title":"Glycoconj J"},{"key":"5277594_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF, Prevalence of lysosomal storage disorders, J AmMed Assoc\n                  281, 249-54 (1999).","journal-title":"J AmMed Assoc"},{"key":"5277594_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","volume":"12","author":"R Pinto","year":"2004","unstructured":"Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H, Pinto E, Silva E, Rocha S, Marcao A, Ribeiro I, Lacerda L, Ribeiro G, Amaral O, Sa Miranda MC, Prevalence of lysoso-mal storage diseases in Portugal, Eur J Hum Genet\n                  12, 87-92 (2004).","journal-title":"Eur J Hum Genet"},{"key":"5277594_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4052\/tigg.4.174","volume":"4","author":"RW Ledeen","year":"1992","unstructured":"Ledeen RW, Yu G, Ganglioside function in the neuron, Trends Glycosci Glycotechnol\n                  4, 174-87 (1992).","journal-title":"Trends Glycosci Glycotechnol"},{"key":"5277594_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","volume":"15","author":"SU Walkley","year":"2004","unstructured":"Walkley SU, Secondary accumulation of gangliosides in lysosomal storage disorders, Semin Cell Dev Biol\n                  15, 433-44 (2004).","journal-title":"Semin Cell Dev Biol"},{"key":"5277594_CR8","unstructured":"Desnick RJ, Ioannou YA, Eng CM, \u00e1-Galactosidase A deficiency: Fabry disease. In The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (McGraw-Hill Inc., 2001), pp. 3733-74."},{"key":"5277594_CR9","unstructured":"Beutler E, Grabowski GA, Gaucher disease. In The Metabolic and Molecular Bases of Inherited Disease,Vol. II, edited by Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (McGraw-Hill Inc., 2001), pp. 3635-68."},{"key":"5277594_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0950-3536(97)80035-2","volume":"10","author":"A Erikson","year":"1997","unstructured":"Erikson A, Bembi B, Schiffmann R, Neuronopathic forms of Gaucher's disease, Baillieres Clin Haematol\n                  10, 711-23 (1997).","journal-title":"Baillieres Clin Haematol"},{"key":"5277594_CR11","unstructured":"Suzuki Y, Oshima A, E. N. \u00e2-galactosidase deficiency (-galactosidosis): GM1 gangliosidosis and Morquio B disease. In The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (McGraw-Hill Inc., 2001), pp. 3775-807."},{"key":"5277594_CR12","unstructured":"Gravel RA, Kaback MM, Proia R, Sandhoff K, Suzuki K, Suzuki K. The GM2 gangliosidosis. In The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (McGraw-Hill Inc., 2001) pp. 3827-76"},{"key":"5277594_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR, Fabry disease, an under-recognized multisystemic disorder: Expert recom-mendations for diagnosis, management, and enzyme replacement therapy, Ann Intern Med\n                  138, 338-46 (2003).","journal-title":"Ann Intern Med"},{"key":"5277594_CR14","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","volume":"144","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ, Brady RO, Fabry disease in childhood, J Pediatr\n                  144, S20-6 (2004).","journal-title":"J Pediatr"},{"key":"5277594_CR15","unstructured":"von Figura K, Gieselmann V, Jaeken J. Metachromatic leukodys-trophy. In The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (McGraw-Hill Inc., 2001), pp. 3695-724."},{"key":"5277594_CR16","unstructured":"Wegner DA, Suzuki K, Suzuki Y, Suzuki K, Galactosylceramide lipidosis: Globoid cell leukodystrophy (Krabbe disease). In The Metabolic and Molecular Bases of Inherited Disease,Vol. II, edited by Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (McGraw-Hill Inc., 2001) pp. 3669-94."},{"key":"5277594_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1001\/archneur.60.3.322","volume":"60","author":"DA Wenger","year":"2003","unstructured":"Wenger DA, Coppola S, Liu SL, Insights into the diagnosis and treatment of lysosomal storage diseases, Arch Neurol\n                  60, 322-8 (2003).","journal-title":"Arch Neurol"},{"key":"5277594_CR18","unstructured":"Schuchman EH, Desnick RJ, Niemann-Pick Disease Types A and B: Acid Sphingomyelinase Deficiences. In The Metabolic and Molecular Bases of Inherited Disease,Vol. II, edited by Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B (McGraw-Hill Inc., 2001), pp. 3589-605."},{"key":"5277594_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cne.10522","volume":"456","author":"JR Sarna","year":"2003","unstructured":"Sarna JR, Larouche M, Marzban H, Sillitoe RV, Rancourt DE, Hawkes R, Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease, J Comp Neurol\n                  456, 279-91 (2003).","journal-title":"J Comp Neurol"},{"key":"5277594_CR20","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/brain\/awg089","volume":"126","author":"M Jeyakumar","year":"2003","unstructured":"Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d'Azzo A, Perry VH, Butters TD, Dwek RA, Platt FM, Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis, Brain\n                  126, 974-87 (2003).","journal-title":"Brain"},{"key":"5277594_CR21","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","volume":"97","author":"R Wada","year":"2000","unstructured":"Wada R, Tifft CJ, Proia RL, Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation, Proc Natl Acad Sci USA\n                  97, 10954-9 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"5277594_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tips.2004.01.004","volume":"25","author":"AH Futerman","year":"2004","unstructured":"Futerman AH, Sussman JL, Horowitz M, Silman I, Zimran A, New directions in the treatment of Gaucher disease, Trends Pharmacol Sci\n                  25, 147-51 (2004).","journal-title":"Trends Pharmacol Sci"},{"key":"5277594_CR23","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1073\/pnas.93.6.2239","volume":"93","author":"DL Vaux","year":"1996","unstructured":"Vaux DL, Strasser A, The molecular biology of apoptosis, Proc Natl Acad Sci USA\n                  93, 2239-44 (1996).","journal-title":"Proc Natl Acad Sci USA"},{"key":"5277594_CR24","doi-asserted-by":"publisher","first-page":"25847","DOI":"10.1074\/jbc.R200008200","volume":"277","author":"YA Hannun","year":"2002","unstructured":"Hannun YA, Obeid LM, The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind, J Biol Chem\n                  277, 25847-50 (2002).","journal-title":"J Biol Chem"},{"key":"5277594_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1043-6618(03)00049-5","volume":"47","author":"R Buccoliero","year":"2003","unstructured":"Buccoliero R, Futerman AH, The roles of ceramide and complex sphingolipids in neuronal cell function, Pharmacol Res\n                  47, 409-19 (2003).","journal-title":"Pharmacol Res"},{"key":"5277594_CR26","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1523\/JNEUROSCI.17-09-02929.1997","volume":"17","author":"A Schwarz","year":"1997","unstructured":"Schwarz A, Futerman AH, Distinct roles for ceramide and gluco-sylceramide at different stages of neuronal growth, J Neurosci\n                  17,2929-38 (1997).","journal-title":"J Neurosci"},{"key":"5277594_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1023\/B:NERE.0000021232.05175.38","volume":"29","author":"C Tardy","year":"2004","unstructured":"Tardy C, Andrieu-Abadie N, Salvayre R, Levade T, Lysosomal storage diseases: Is impaired apoptosis a pathogenic mechanism? Neurochem Res\n                  29, 871-80 (2004).","journal-title":"Neurochem Res"},{"key":"5277594_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng1095-170","volume":"11","author":"K Sango","year":"1995","unstructured":"Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL, Mouse models of Tay-Sachs and Sandhoff diseases dif-fer in neurologic phenotype and ganglioside metabolism, Nature Genetics\n                  11, 170-6 (1995).","journal-title":"Nature Genetics"},{"key":"5277594_CR29","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/hmg\/6.11.1879","volume":"6","author":"JQ Huang","year":"1997","unstructured":"Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA, Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases, Hum Mol Genet\n                  6, 1879-85 (1997).","journal-title":"Hum Mol Genet"},{"key":"5277594_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/(SICI)1096-8628(20000320)91:3<222::AID-AJMG13>3.0.CO;2-#","volume":"91","author":"LS Finn","year":"2000","unstructured":"Finn LS, Zhang M, Chen SH, Scott CR, Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: Molecular and pathological analyses, Am J Med Genet\n                  91, 222-6 (2000).","journal-title":"Am J Med Genet"},{"key":"5277594_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/357407a0","volume":"357","author":"VLJ Tybulewicz","year":"1992","unstructured":"Tybulewicz VLJ, Tremblay ML, LaMrca ME, Willemsen R, Stubblefield BK, Winfield S, Zablocka B, Sidransky E, Martin BM, Huang SP, Mintzer KA, Westphal H, Mulligan RC, Ginns EI, Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene, Nature\n                  357, 407-10 (1992).","journal-title":"Nature"},{"key":"5277594_CR32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10038-004-0155-2","volume":"49","author":"YB Hong","year":"2004","unstructured":"Hong YB, Kim EY, Jung SC, Down-regulation of Bcl-2 in the fetal brain of the Gaucher disease mouse model: A possible role in the neuronal loss, J Hum Genet\n                  49, 349-54 (2004).","journal-title":"J Hum Genet"},{"key":"5277594_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0304-3940(02)00655-9","volume":"330","author":"M Jatana","year":"2002","unstructured":"Jatana M, Giri S, Singh A, Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine, Neurosci Lett\n                  330, 183-7 (2002).","journal-title":"Neurosci Lett"},{"key":"5277594_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/hmg\/11.11.1343","volume":"11","author":"R Myerowitz","year":"2002","unstructured":"Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL, Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling, Hum Mol Genet\n                  11, 1343-50 (2002).","journal-title":"Hum Mol Genet"},{"key":"5277594_CR35","doi-asserted-by":"publisher","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","volume":"274","author":"E Korkotian","year":"1999","unstructured":"Korkotian E, Schwarz A, Pelled D, Schwarzmann G, Segal M, Futerman AH, Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons, J Biol Chem\n                  274, 21673-8 (1999).","journal-title":"J Biol Chem"},{"key":"5277594_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1005622001239","volume":"23","author":"D Pelled","year":"2000","unstructured":"Pelled D, Shogomori H, Futerman AH, The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by Imiglucerase, J Inherit Metab Dis\n                  23, 175-84 (2000).","journal-title":"J Inherit Metab Dis"},{"key":"5277594_CR37","doi-asserted-by":"publisher","first-page":"23594","DOI":"10.1074\/jbc.M300212200","volume":"278","author":"E Lloyd-Evans","year":"2003","unstructured":"Lloyd-Evans E, Pelled D, Riebeling C, Bodennec J, de-Morgan A, Waller H, Schiffmann R, Futerman AH, Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms, J Biol Chem\n                  278, 23594-9 (2003).","journal-title":"J Biol Chem"},{"key":"5277594_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20030613","volume":"375","author":"E Lloyd-Evans","year":"2003","unstructured":"Lloyd-Evans E, Pelled D, Riebeling C, Futerman AH, Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms, Biochem J\n                  375, 561-5 (2003).","journal-title":"Biochem J"},{"key":"5277594_CR39","doi-asserted-by":"publisher","first-page":"29496","DOI":"10.1074\/jbc.M302964200","volume":"278","author":"D Pelled","year":"2003","unstructured":"Pelled D, Lloyd-Evans E, Riebeling C, Jeyakumar M, Platt FM, Futerman AH, Inhibition of calcium uptake via the sarco\/endoplasmic reticulum Ca2-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin, J Biol Chem\n                  278, 29496-501 (2003).","journal-title":"J Biol Chem"},{"key":"5277594_CR40","first-page":"472","volume":"4","author":"R. M. Lachmann","year":"2003","unstructured":"Lachmann RH, Miglustat. Oxford GlycoSciences\/Actelion, Curr Opin Investig Drugs\n                  4, 472-9 (2003).","journal-title":"Curr Opin Investig Drugs"},{"key":"5277594_CR41","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1096\/fj.02-0149fje","volume":"16","author":"J Bodennec","year":"2002","unstructured":"Bodennec J, Pelled D, Riebeling C, Trajkovic S, Futerman AH, Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide, Faseb J\n                  16, 1814-6 (2002).","journal-title":"Faseb J"},{"key":"5277594_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1471-4159.2004.02457.x","volume":"90","author":"R Buccoliero","year":"2004","unstructured":"Buccoliero R, Bodennec J, van Echten-Deckert G, Sandhoff K, A.H. F, Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease, J Neurochem\n                  90, 80-8 (2004).","journal-title":"J Neurochem"},{"key":"5277594_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1046\/j.1365-2990.2003.00455.x","volume":"29","author":"D Pelled","year":"2003","unstructured":"Pelled D, Riebeling C, van Echten-Deckert G, Sandhoff K, Futerman AH, Reduced rates of axonal and dendritic growth in. Raas-Rothschild et al. embryonic hippocampal neurones cultured from a mouse model of Sandhoff disease, Neuropathol Appl Neurobiol\n                  29, 341-9 (2003).","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5277594_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.semcdb.2004.03.003","volume":"15","author":"L Ginzburg","year":"2004","unstructured":"Ginzburg L, Kacher Y, Futerman AH, The pathogenesis of gly-cosphingolipid storage disorders, Semin Cell Dev Biol\n                  15, 417-31 (2004).","journal-title":"Semin Cell Dev Biol"},{"key":"5277594_CR45","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1023\/A:1005590316064","volume":"22","author":"J Tohyama","year":"1999","unstructured":"Tohyama J, Oya Y, Ezoe T, Vanier MT, Nakayasu H, Fujita N, Suzuki K, Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activa-tor protein-deficient mouse but not in fibroblasts of patients with Farber disease, J Inherit Metab Dis\n                  22, 649-62 (1999).","journal-title":"J Inherit Metab Dis"},{"key":"5277594_CR46","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1074\/jbc.270.18.10990","volume":"270","author":"A Schwarz","year":"1995","unstructured":"Schwarz A, Rapaport E, Hirschberg K, Futerman AH, A regulatory role for sphingolipids in neuronal growth. Inhibition of sphin-golipid synthesis and degradation have opposite effects on axonal branching, J Biol Chem\n                  270, 10990-8 (1995).","journal-title":"J Biol Chem"}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:GLYC.0000046272.38480.ef.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:GLYC.0000046272.38480.ef\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:GLYC.0000046272.38480.ef.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T06:08:27Z","timestamp":1754460507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:GLYC.0000046272.38480.ef"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["5277594"],"URL":"https:\/\/doi.org\/10.1023\/b:glyc.0000046272.38480.ef","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"type":"print","value":"0282-0080"},{"type":"electronic","value":"1573-4986"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}